EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Host Reticulocyte Redox Attenuation Creates a Protective Niche for Artemisinin Tolerance in Plasmodium falciparum

Christeen Davis iD, Lakshmi V S iD, Sreenath Meloth iD, Renugah Naidu iD, Trang T T Chu iD, Rema Sreejith, Kamalakannan Vijayan iD, Manish Kumar iD, Dhanasekaran Shanmugam iD, Rajesh Chandramohanadas iD

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiag290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Christeen Davis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathogen Biology, Biotechnology Research and Innovation Council (BRIC)-Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, …. Hauptthemen laut MEDLINE: Artemisinins, Reticulocytes, Plasmodium falciparum, Antimalarials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Council of Scientific and Industrial Research, BRIC-Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Artemisinin-based combination therapies are the cornerstone of Plasmodium falciparum malaria treatment; however, delayed parasite clearance and treatment failure occur even in the absence of established parasite genetic resistance. While parasite-intrinsic resistance mechanisms have been extensively studied, the contribution of host erythroid heterogeneity to antimalarial drug response remains poorly defined.

Methods

Highly purified human CD71+ reticulocytes and mature erythrocytes were used to assess parasite invasion, intraerythrocytic development, and drug susceptibility. Integrated metabolomic and proteomic analyses characterized host cell environments. Parasite responses to artemisinin derivatives and antimalarials with distinct mechanisms of action were systematically evaluated.

Results

P. falciparum preferentially invaded reticulocytes and exhibited accelerated asexual development within these cells. Multiomics analyses demonstrated that reticulocytes provide a metabolically enriched, antioxidant-modulated intracellular environment, marked by increased nucleotide precursors, enhanced glutathione metabolism, and elevated levels of reactive oxygen species-detoxifying enzymes. Parasites developing within reticulocytes showed significantly reduced susceptibility to artemisinin and dihydroartemisinin, as well as to other redox-active antimalarials, while maintaining comparable sensitivity to drugs with nonoxidative mechanisms. Reticulocyte-resident parasites also demonstrated enhanced survival and recrudescence following artemisinin exposure.

Conclusions

Erythroid maturation state is a key host determinant of antimalarial drug efficacy. Reticulocytes form a redox-protected intracellular niche that attenuates drug-induced oxidative stress and promotes parasite persistence, consistent with a host cell-mediated tolerance phenotype. These findings provide a mechanistic framework for variability in treatment outcomes associated with reticulocytosis and anemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsReticulocytesPlasmodium falciparumAntimalarialsDrug ToleranceHumansOxidation-ReductionErythrocytesDrug ResistanceMalaria, FalciparumReactive Oxygen SpeciesOxidative Stress

Stichwörter der Autor:innen

Plasmodium falciparumartemisinin tolerancehost cell-mediated drug responseoxidative stressredox attenuationreticulocyte tropism

Substanzen

ArtemisininsAntimalarialsartemisininReactive Oxygen Species

Autor:innen und Institutionen

  • Division of Pathogen Biology, Biotechnology Research and Innovation Council (BRIC)-Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, Kerala, India.
  • Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Regional Centre for Biotechnology, Faridabad, Haryana, India.
  • Pillar of Engineering Product Development, Singapore University of Technology and Design, Singapore, Singapore.
  • Department of Obstetrics and Gynaecology, Cosmopolitan Hospital, Thiruvananthapuram, Kerala, India.
  • School of Biology, Indian Institute for Science Education and Research, Thiruvananthapuram, Kerala, India.

ORCID-Profile: Christeen Davis, Lakshmi V S, Sreenath Meloth, Renugah Naidu, Trang T T Chu, Kamalakannan Vijayan, Manish Kumar, Dhanasekaran Shanmugam, Rajesh Chandramohanadas

Förderung

  • Council of Scientific and Industrial Research
  • BRIC-Rajiv Gandhi Centre for Biotechnology
  • Department of Biotechnology
  • Science and Engineering Research Board

Zitieren

APA

Davis, C., V S, L., Meloth, S., Naidu, R., Chu, T. T. T., Sreejith, R., Vijayan, K., Kumar, M., Shanmugam, D., & Chandramohanadas, R. (2026). Host Reticulocyte Redox Attenuation Creates a Protective Niche for Artemisinin Tolerance in Plasmodium falciparum. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag290

Vancouver

Davis C, V S L, Meloth S, Naidu R, Chu TTT, Sreejith R, et al. Host Reticulocyte Redox Attenuation Creates a Protective Niche for Artemisinin Tolerance in Plasmodium falciparum. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag290

BibTeX
@article{Davis2026,
  author = {Davis, Christeen and V S, Lakshmi and Meloth, Sreenath and Naidu, Renugah and Chu, Trang T T and Sreejith, Rema and Vijayan, Kamalakannan and Kumar, Manish and Shanmugam, Dhanasekaran and Chandramohanadas, Rajesh},
  title = {Host Reticulocyte Redox Attenuation Creates a Protective Niche for Artemisinin Tolerance in Plasmodium falciparum},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiag290}
}
Kostenlos starten →